CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 144 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $61,000 | -17.6% | 26,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $74,000 | -12.9% | 26,000 | -12.8% | 0.00% | 0.0% |
| Q3 2017 | $85,000 | +3.7% | 29,800 | -9.7% | 0.00% | 0.0% |
| Q2 2017 | $82,000 | -32.8% | 33,000 | -2.7% | 0.00% | -50.0% |
| Q1 2017 | $122,000 | -10.3% | 33,900 | -11.5% | 0.00% | 0.0% |
| Q4 2016 | $136,000 | -9.3% | 38,300 | +3.0% | 0.00% | 0.0% |
| Q3 2016 | $150,000 | – | 37,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KLP Enterprises, LLC | 6,865,006 | $24,302,000 | 100.00% |
| TSP Capital Management Group, LLC | 886,398 | $3,138,000 | 1.60% |
| Marcus Capital, LLC | 109,950 | $389,000 | 0.42% |
| RTW INVESTMENTS, LP | 239,662 | $848,000 | 0.32% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 6,195,855 | $21,933,000 | 0.31% |
| Benchmark Capital Advisors | 66,800 | $236,000 | 0.20% |
| Bellevue Group AG | 160,000 | $566,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 632,944 | $2,241,000 | 0.09% |
| PDT Partners, LLC | 369,300 | $1,307,000 | 0.09% |
| Vident Investment Advisory, LLC | 196,715 | $696,000 | 0.08% |